Risk Assessment
Watch the DPNCheck Overview

DPNCheck

DPNCheck can improve the effectiveness of neuropathy detection programs and is ideal for:

• Risk Based Organizations
• Clinic Based Health Risk Assessments
• Health Risk Assessment Service Providers for In-home Use

Why Use Nerve Conduction to Detect Peripheral Neuropathy?

The prevalence of peripheral neuropathy in the general population is 10% and in patients over 65 it increases up to 25%¹. Over 50% of patients with diabetes will develop neuropathy². The rate of diagnosed neuropathy is often much lower than the prevalence rate resulting in unidentified risk.

• Traditional detection tools (monofilament or tuning fork) detect only late stage neuropathy and have low sensitivity³
• Due to the subjective nature of these tests they are usually performed by physicians not staff
• Compliance rates for the performance of these tests are typically poor
• Sural nerve conduction detects peripheral neuropathy with high diagnostic sensitivity at all stages of severity

Benefits of Improved Peripheral Neuropathy Detection in a Managed Care Organization:

• Accurately risk assess members
• Early diagnosis of peripheral neuropathy presents opportunities to intervene and reduce costs
• Identify those patients with neuropathy that are at highest risk for neuropathy related complications such as foot ulcers, neuropathic pain, and falls
• Efficient and cost effective testing

DPNCheck Clinical Validation

DPNCheck has been clinically validated in numerous peer-reviewed journal publications and clinical conference presentations. Click here to view the complete list.